The common man, whose concerns were at the heart of the Congress-led United Progressive Alliance’s two successful election campaigns, doesn’t seem to be the focus of finance minister Pranab Mukherjee’s budget. Experts and political analysts say the aam admi doesn’t appear to be the dominant concern anymore, prompting speculation about Congress party chief Sonia Gandhi’s role. She has thus far been setting the UPA’s social agenda through the National Advisory Council...

-The Telegraph The economic survey has challenged an international assessment that has ranked India 125, or near-bottom, among 132 countries on environmental performance, but has acknowledged that air pollution has increased to alarming levels. The survey, released by the Union government today, has questioned the methodology of the Environmental Performance Index 2012 that has assigned air quality in India a rank of 132, the worst in the world, and similarly low ranks...

-PTI The UIDAI's Aadhaar project for providing unique identity numbers to residents, has huge potential to improve the delivery of social sector schemes like rural employment guarantee, the Economic Survey 2011-12 said. "Aadhaar has huge potential for improving operations and delivery of services," the survey said. The Unique Identification Authority of India (UIDAI), attached to the Planning Commission, is engaged in providing residents in the country a Unique Identification number (called Aadhaar) linked...

-The Business Standard   Major subsidies extended by the government are likely to jump to Rs 1,34,411 crore during 2011-12 The Survey has warned of deteriorating fiscal health due to a mounting subsidy burden. The huge outgo over the past year has been largely on account of the global rally in crude oil prices, the fertiliser subsidy and state-controlled foodgrain prices, it said. It also blamed ‘coalition politics and federal considerations’ for holding...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...